Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America
- PMID: 11350553
- DOI: 10.1046/j.1440-1746.2001.02470.x
Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America
Abstract
Background: Measurement of serum alpha-fetoprotein (AFP) and abdominal ultrasound (US) examination are used for the early detection of hepatocellular carcinoma (HCC) in chronic liver disease patients. However, the accuracy and usefulness of these tests in a clinical setting in the United States of America have not been clarified.
Methods: We conducted a 7-year prospective surveillance study by using both AFP and US to detect HCC in 602 patients with chronic viral hepatitis. Our main goal was to determine the optimal test for detection of early HCC. We also assessed the clinical outcome of HCC patients identified during this time period.
Results: Thirty-one cases of HCC were detected. Serum AFP levels were elevated in 74% of HCC patients, but was also high in 10% of patients who did not develop HCC. The positive predictive value for AFP to detect HCC was only 12% or less for all AFP cut-off values, and the maximum joint sensitivity and specificity as determined by receiver operator characteristic analysis was approximately 65 and 90%, respectively. Abdominal US identified all 31 cases of HCC. The positive predictive value for US examinations to detect HCC was 78%, while the sensitivity and specificity was 100 and 98%, respectively. After detection of HCC, 24 (77%) patients died within a mean of 16.7 +/- 19.4 months.
Conclusions: Our study indicates that US examination was more accurate in detecting HCC. Because of its poor predictive value and low sensitivity, serum AFP should not be used as the only test for screening and surveillance for HCC.
Comment in
-
Optimal surveillance of hepatocellular carcinoma in patients with chronic viral hepatitis.J Gastroenterol Hepatol. 2001 Jul;16(7):715-7. doi: 10.1046/j.1440-1746.2001.02511.x. J Gastroenterol Hepatol. 2001. PMID: 11446876 No abstract available.
Similar articles
-
Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013346. doi: 10.1002/14651858.CD013346.pub2. Cochrane Database Syst Rev. 2021. PMID: 33855699 Free PMC article.
-
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19. J Gastroenterol Hepatol. 2008. PMID: 18422961
-
Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein.Ann Surg Oncol. 1999 Mar;6(2):178-85. doi: 10.1007/s10434-999-0178-1. Ann Surg Oncol. 1999. PMID: 10082044
-
Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.Cochrane Database Syst Rev. 2003;(2):CD002799. doi: 10.1002/14651858.CD002799. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2012 Sep 12;(9):CD002799. doi: 10.1002/14651858.CD002799.pub2 PMID: 12804438 Updated. Review.
-
[Screening of hepatocellular carcinoma: role of the alpha-fetoprotein (AFP) and ultrasonography].Recenti Prog Med. 2005 Jun;96(6):295-9; quiz 328. Recenti Prog Med. 2005. PMID: 16078760 Review. Italian.
Cited by
-
Comparison of a multitarget blood test to ultrasound and alpha-fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta-analysis.Hepatol Commun. 2022 Oct;6(10):2925-2936. doi: 10.1002/hep4.2045. Epub 2022 Aug 9. Hepatol Commun. 2022. PMID: 35945907 Free PMC article.
-
Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases.Br J Radiol. 2012 Apr;85(1012):351-7. doi: 10.1259/bjr/20440141. Epub 2011 Jan 11. Br J Radiol. 2012. PMID: 21224305 Free PMC article.
-
Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.Hepatol Int. 2008 Mar;2(1):17-30. doi: 10.1007/s12072-007-9038-x. Epub 2007 Dec 29. Hepatol Int. 2008. PMID: 19669276 Free PMC article.
-
Regular surveillance by imaging for early detection and better prognosis of hepatocellular carcinoma in patients infected with hepatitis C virus.J Gastroenterol. 2010;45(1):105-12. doi: 10.1007/s00535-009-0131-x. Epub 2009 Oct 29. J Gastroenterol. 2010. PMID: 19866332
-
Diagnosis of hepatocellular carcinoma.World J Gastroenterol. 2009 Mar 21;15(11):1301-14. doi: 10.3748/wjg.15.1301. World J Gastroenterol. 2009. PMID: 19294759 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical